|
|
56 East Bell Drive, PO Box 587
Warsaw, IN 46581-0587 USA
phone:(574) 267-6639
fax:(574) 267-8137
|
|
| Symbol |
BMET |
| Exchange |
NASDAQ |
| Founded |
1977 |
| Employees |
3620 |
|
|
| www.biomet.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Reconstructive devices, fixation products, spinal products and dental reconstructive implants. |
|
| Management |
| Jeffrey R. Binder, President and Chief Executive Officer, Biomet, Inc.; Jonathan J. Coslet, Senior Partner, TPG Capital, L.P.; Michael Dal Bello, Principal, Private Equity Group, The Blackstone Group; Adrian Jones, Managing Director, Goldman, Sachs & Co.; David McVeigh, Executive Director, The Blackstone Group |
| |
|
|
|
|
|
|
|
| Keywords |
| orthopedic, arthroscopic, rotator cuff tears, cartilage, sutures, arthritis |
|
|
|
| Description |
|
Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. The Company's product portfolio encompasses reconstructive products, including orthopedic joint replacement devices, bone cements and accessories, and dental reconstructive implants; fixation products, including electrical bone growth stimulators, internal and external orthopedic fixation devices, craniomaxillofacial implants and bone substitute materials; spinal products, including spinal stimulation devices, spinal hardware and orthobiologics; and other products, such as arthroscopy products and softgoods and bracing products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in more than 100 countries. |
|
| Products / Services |
Biomet, Inc. designs and manufactures orthopaedic implants, instrumentation, and various related medical products related to the replacement of arthritic hips, knees, shoulders, and elbows. Biomet's offerings are classified into four product groups: reconstructive devices, fixation products, spinal products and other products. They include reconstructive and fixation devices, electrical bone growth stimulators, orthopedic support devices, operating room supplies, general surgical instruments, arthroscopy products, spinal products, bone cements and accessories, bone substitute materials, craniomaxillofacial implants and instruments and dental reconstructive implants and associated instrumentation.
|
|
| Technology / Differentiation |
| ArCom Polyethylene, RingLoc Acetabular Series, Titanium Closed Pore Plasma Spray Coating. |
|
|
| Competitors / Substitutes / Alternatives |
DePuy Inc., Medtronic Sofamor Danek, Inc., Zimmer Holdings Inc.
|
|
| Funding |
| The Company's principal subsidiaries include Biomet Orthopedics, Inc., Biomet Manufacturing Corp., EBI, L.P., BioMer CV (the Biomet Merck Joint Venture), Implant Innovations, Inc., Walter Lorenz Surgical, Inc. and Arthrotek, Inc. In March 2004, the Company acquired Merck KGaA's 50% interest in the Biomet-Merck Joint Venture |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members